Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

OPKO Health, Inc. OPK

Set alert

Price alert · OPK

All alert types
1.78 USD +0.06 +3.49%

As of Nov 3, 1:35 PM ET

Bid
1.77 × 82
Ask
1.78 × 107
1.74 Day range 1.81
0.98 52-week range 1.81
YTD
+41.27%
1 year
+27.14%
Open
1.75
Prev close
1.72
Mkt cap
1.32B
Vol
1.39M
Avg vol
3.55M
EPS
-0.09
P/E
0.00
Div yield
0.00%
More statistics
Low
1.74
High
1.81
Forward P/E
-5.01
Beta
1.53
Short ratio
7.73
Inst. own
27.61%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
1.56
200-d avg
1.34
1y target
4.15

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 16, 2026Rating: Barrington Research · Market Perform → Outperform
  • Oct 16, 2026Rating: Piper Sandler · Overweight → Overweight
Signals (15)
NameDateAgo
SMA: BullishOct 19, 20262 weeks ago
MACD: Buy SignalOct 19, 20262 weeks ago
SMA: BearishOct 16, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
RSI: OversoldOct 13, 20263 weeks ago
SMA: BearishOct 6, 20264 weeks ago
SMA: BearishOct 1, 20261 month ago
MACD: Sell SignalSep 25, 20261 month ago
MACD: Buy SignalSep 18, 20261 month ago
MACD: Sell SignalSep 10, 20261 month ago
RSI: OverboughtSep 2, 20262 months ago
SMA: BullishAug 19, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BullishAug 7, 20262 months ago

Analyst view

Consensus: buy

Buy
Price target (mean) 4.15 +133.1% upside
Target (low)
2.25
Target (mean)
4.15
Target (high)
8.50
Ratings (0m) 6 5 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy2
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

OPK analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.06333-0.08 – -0.050.000.0%136.62M-9.9%3
Next quarter-0.06-0.07 – -0.04-0.0358-67.6%145.48M-2.0%3
Current year-0.21-0.22 – -0.200.000.0%569.86M-6.1%2
Next year-0.34333-0.48 – -0.26-0.21-63.5%495.12M-13.1%3

Upgrades and downgrades

The latest rating changes

OPK analyst upgrades and downgrades
DateFirmActionFromTo
Oct 16, 2026Piper SandlerReiteratedOverweightOverweight
Oct 16, 2026Barrington ResearchUpgradeMarket PerformOutperform
Apr 29, 2026Barrington ResearchDowngradeOutperformMarket Perform
Mar 2, 2026Barrington ResearchMaintainedOutperformOutperform
Nov 20, 2025JP MorganInitiated—Neutral
Oct 31, 2025JefferiesDowngradeBuyHold
Oct 30, 2025Barrington ResearchMaintainedOutperformOutperform
May 1, 2025Barrington ResearchMaintainedOutperformOutperform
Apr 25, 2025JP MorganInitiated—Neutral
Apr 7, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 19, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 12, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 12, 2025Barrington ResearchMaintainedOutperformOutperform
Mar 3, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 28, 2025Barrington ResearchMaintainedOutperformOutperform
Jan 8, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 8, 2024Barrington ResearchMaintainedOutperformOutperform
Sep 26, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 20, 2024Barrington ResearchMaintainedOutperformOutperform
Sep 17, 2024Piper SandlerReiteratedOverweightOverweight
Sep 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 8, 2024Barrington ResearchMaintainedOutperformOutperform
Jul 18, 2024Piper SandlerMaintainedOverweightOverweight
May 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 3, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 1, 2024Barrington ResearchMaintainedOutperformOutperform
Apr 1, 2024Piper SandlerReiteratedOverweightOverweight
Feb 28, 2024HC Wainwright & Co.ReiteratedBuyBuy
Feb 28, 2024Barrington ResearchMaintainedOutperformOutperform
Aug 7, 2023HC Wainwright & Co.ReiteratedBuyBuy